Abstract:
Disclosed are methods, systems, apparatus, and products, including a method for operating a respiratory care device that includes collecting at a respiratory care device data representative of operation of the respiratory care device, and communicating to a computing-based device external to the respiratory care device at least some of the collected data to control the operability of the respiratory care device. In some embodiments, the method may further include communicating to the respiratory care device data to controllably change one or more operation parameters of the respiratory care device to cause a change in the operation of the respiratory care device, changing the operation parameters of the respiratory care device according to the communicated data, and communicating to the external computing-based device resultant data representative of operation of the respiratory care device resulting from the controllable change to the one or more operation parameters.
Abstract:
An enhanced system and method for executing options trades are disclosed. The lead market maker entitlements are integrated with sophisticated order types, including dark order types, so that the lead marker maker is guaranteed an allocation of the trade if the lead market maker is at the NBBO when an order priced at or better than the NBBO is received. The lead market maker is not provided an opportunity to price improve to execute with a specific incoming order. Additionally, market makers who are not the lead market maker in an option series may be granted the privileges of a lead market maker for the purpose of executing with a specific incoming directed order if the designated market maker is at the NBBO when a directed order priced at or better than the NBBO is received. The system and method disclosed encourages market makers to quote the best price possible, which in turn has the effect of narrowing spreads. Furthermore, as only displayed orders at the NBBO are eligible to execute ahead of market makers quoting at the NBBO, the system and method encourages users to display their best prices and sizes to the marketplace.
Abstract:
Devices, systems, and methods, include an oxygen delivery device that includes an oxygen delivery module, at least one sensor to detect patient breathing, and a controller configured to control the oxygen delivery module to cause the oxygen delivery module to deliver oxygen to the patient based on data from the at least one sensor such that in response to a determination, based on data from the at least one sensor, that no breathing is detected for a first pre-determined period of time, the controller causes the oxygen delivery module to deliver oxygen to the patient in continuous flow mode, and in response to a determination, based on additional data from the at least one sensor, that breathing is detected for a second period of time, the controller causes the oxygen delivery module to deliver oxygen to the patient in a pulse flow mode.
Abstract:
Modular support systems for supporting multi story buildings including plates having bottom major faces and top major faces, the plates defining bolt holes extending through the plates, vertical columns extending from bottom ends to top ends opposite the bottom ends, the bottom ends of the vertical columns being welded to the top major faces of the plates, and horizontal columns having bottom sides and top sides opposite the bottom sides, the bottom sides of the horizontal columns being welded to the top end of the vertical columns. In some examples, the horizontal column defines bolt holes being positioned to align with the bolt holes defined in the plate. Some examples include pluralities of structural units selectively fastened together in a vertical arrangement, with each structural unit configured to selectively couple with vertically adjacent structural unit. Some examples define buildings including disclosed support systems.
Abstract:
Multivalent binding peptides, including bi-specific binding peptides, having immunoglobulin effector function are provided, along with encoding nucleic acids, vectors and host cells as well as methods for making such peptides and methods for using such peptides to treat or prevent a variety of diseases, disorders or conditions, as well as to ameliorate at least one symptom associated with such a disease, disorder or condition.
Abstract:
Multivalent binding peptides, including bi-specific binding peptides, having immunoglobulin effector function are provided, along with encoding nucleic acids, vectors and host cells as well as methods for making such peptides and methods for using such peptides to treat or prevent a variety of diseases, disorders or conditions, as well as to ameliorate at least one symptom associated with such a disease, disorder or condition.
Abstract:
Single chain fusion proteins that specifically bind to a TCR complex or a component thereof, such as TCRα, TCRβ, or CD3ε, along with compositions and methods of use thereof are provided.
Abstract:
A hydraulic bolt tensioner has a reduced height by virtue of inner seals between a cylinder and piston being aligned along a same plane. The tensioner also has a reduced width by virtue of carbon fiber would about the tensioner's housing, reducing the need for a certain thickness of material used for the tensioner's housing.
Abstract:
This disclosure provides a multi-specific fusion protein composed of a CD72-ligand binding domain and another binding domain specific for a heterologous target, such as a B-cell specific protein. The multi-specific fusion protein may also include an intervening domain that separates the other domains. This disclosure also provides polynucleotides encoding the multi-specific fusion proteins, compositions of the fusion proteins, and methods of using the multi-specific fusion proteins and compositions.
Abstract:
The present disclosure provides a humanized anti-CD37 small modular immunopharmaceutical (SMIP) molecule, as well as synergistic combination therapies of CD37-specific binding molecules (such as anti-CD37 SMIP proteins or antibodies) with bifunctional chemotherapeutics (such as bendamustine) that can be administered concurrently or sequentially, for use in treating or preventing B cell related autoimmune, inflammatory, or hyperproliferative diseases.